Investor relations ratingHamburglar48 , thenks for finding that clinic closing tidbit ; it's one of a few questions I've been attempting to get answers to for all year,essentially .
I've been asking questions and failing to get answers which rarely happens when I contact the investor relations dept of a company so ,I'm posting this comment in hopes that somebody from the company reads our posts which I feel in unlikely but hey , you never know.
Here's a partial text of my third e mail attempt
'I took the time to listen to the call , tried to enter the queue by pressing star 1 , to get some questions answered and some further clarifications and it didn't work.
So here are some of my questions.
Going back to April 25,2022 ,the first agreement with Beedie Capital ,was the company thinking the whole amount would be eventually utilized or just partially used?
Why has the company failed to get revenues and costs more balanced? They mentioned the closure in St. Louis realizing a $2 million savings ( most of which seems to have been captured?) but only a 1% and 5% decline in opex over the 3 month and 9 month period. Rationalizing costs was mentioned as the focus for the 9 months so why has nothing changed? What are the further levers the company can pull on?
They mentioned clinic services - one was closed , guessing St. Louis and one was sold. I would like to know what was sold even if it was immaterial?
Does the company still own the bariatic services clinic?
Of the $28 million owed to Bank of Nova Scotia and Beedie Capital , how much is owed to the Bank of Nova Scotia?
Can you explain exactly what is meant by third party agreements?
On average , how much does Pharmapod cost a clinic?
I'm willing to have a discussion if that suits you better. Just let me know.
Thanks"
I have made three e mails personally and now I'm up to four voice mails ( the last one, just now) with no response.
I even had an investment professional forward my e mail almost two weeks ago , thinking a professional e mail might get a response , with no response so far.
Here's what happens when you phone them @ 1-416-388-7119 : makes you wonder if one of their cost savings was Investor Relations?
You call the number and then after a few rings , voicemail picks up but with no identifer, it's actually the phone of Mark Sakamoto.
The last few days , I've tried corporate HQ which offers two basic options - company directory A-Z or Z-A and reception. If you try the directory , you get the same two individuals in both directions and then nothing.
Reception gets you the mailbox which is full.
This is an exercise in futility.
Sad to be posting this but this needs to be improved.
THE WORST IR ever?